Glucocorticoid-induced osteoporosis

Academic Article

Abstract

  • Therapeutic use of glucocorticoids can lead to many well-known adverse events. Of all potential serious side effects, glucocorticoid-induced osteoporosis (GIOP) is one of the most devastating complications of protracted glucocorticoid therapy in rheumatoid arthritis. GIOP is the most common form of drug-induced osteoporosis. Although much has been written about the association of glucocorticoids with bone disease among patients with chronic inflammatory conditions, many issues remain unsettled. This article focuses on areas of continued controversies, including the epidemiology and pathogenesis of GIOP, specification of a "safe" dose, methods for diagnosis of GIOP, and an evidence-based approach for GIOP prevention.
  • Authors

    Digital Object Identifier (doi)

    Author List

  • Saag KG
  • Start Page

  • 135
  • End Page

  • 157
  • Volume

  • 32
  • Issue

  • 1